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Type I Interferons Potently Enhance Humoral
Immunity and Can Promote Isotype Switching
by Stimulating Dendritic Cells In Vivo
only by immune cells but by virtually all cells, making
them very effective in alerting the host to infection. They
induce a variety of genes that can inhibit virus replication
at several stages, conferring an anti-viral state on target
cells (Kirchner, 1984), and are capable of activating both
Agnes Le Bon,* Giovanna Schiavoni,†
Giuseppina D’Agostino,† Ion Gresser,‡
Filippo Belardelli,† and David F. Tough*§
*The Edward Jenner Institute for Vaccine Research
Compton, Newbury
NK cells and macrophages (Belardelli, 1995; Biron et al.,Berkshire RG20 7NN
1999; Bogdan, 2000). Hence, their role in the nonspecificEngland
resistance to virus spread is well recognized. Less clear†Laboratory of Virology
is their importance in the generation of an antigen-spe-Istituto Superiore di Sanita`
cific adaptive immune response.Viale Regina Elena 299
IFN-I have been shown to exert immunomodulatory00161 Rome
effects in vitro. These include upregulation of MHC classItaly
I (Lindahl et al., 1976), promotion of Th1 responses by‡ INSERM U255-Institut Curie
human but not mouse T cells (Brinkmann et al., 1993;26 rue d’Ulm
Wenner et al., 1996), and enhancement of the matura-75248 Paris Cedex 05
tion/activation state of dendritic cells (DC) generatedFrance
from human peripheral blood or mouse bone marrow
precursors (Luft et al., 1998; Paquette et al., 1998; Gal-
lucci et al., 1999; Radvanyi et al., 1999; Santini et al.,Summary
2000). In addition, IFN-a was shown to act as a survival
factor when added to type 2 DC precursors isolated fromType I interferons (IFN-I) are rapidly induced following
human blood, although it did not induce DC maturation.infection and play a key role in nonspecific inhibition
Interestingly, these cells produce very large quantitiesof virus replication. Here we have investigated the ef-
of IFN-a/b in response to viruses, implying that IFN-Ifects of IFN-I on the generation of antigen-specific
are an autocrine survival factor for some DC precursorsantibody responses. The data show that IFN-I potently
(Kadowaki et al., 2000). Thus, the ability of IFN-I to influ-enhance the primary antibody response to a soluble
ence the activity of key immune cells suggests that theseprotein, stimulating the production of all subclasses
cytokines could serve as a link between the innate re-of IgG, and induce long-lived antibody production and
sponse to viruses and the adaptive immune response.immunological memory. In addition, endogenous pro-
However, IFN-I have also been shown to exert potentduction of IFN-I was shown to be essential for the
inhibitory effects on antibody production (Gisler et al.,adjuvant activity of CFA. Finally, IFN-I enhanced the
1974) and T cell proliferation (Lindahl-Magnusson et al.,antibody response and induced isotype switching
1972) in vitro, raising the question of whether these cyto-when dendritic cells were the only cell type responding
kines would act in a stimulatory or inhibitory manner into IFN-I. The data reveal the potent adjuvant activity
vivo.of IFN-I and their important role in linking innate and
Studies conducted by several groups in the 1970’sadaptive immunity.
aimed at determining the effects of systemic administra-
tion of IFN-I on the in vivo antibody response to sheepIntroduction
red blood cells provided conflicting results in this regard
(Braun and Levy, 1972; Chester et al., 1973; Brodeur and
Signals generated after the recognition of infectious
Merigan, 1974, 1975; Strannegard et al., 1978; Vignaux et
agents by cells of the innate immune system are thought
al., 1980). While some authors reported an inhibitory
to be important in triggering the antigen-specific adap- effect of IFN-I, others failed to see this inhibition and/
tive immune response (Medzhitov and Janeway, 1997). or observed a modest stimulatory effect of IFN-I. The
In this regard, cytokines expressed in response to different results may have been related to the timing
pathogen encounter may play a key role because of of injection of IFN-I, with the general trend being that
their potential to modify both the magnitude and the treatment with IFN-I prior to immunization inhibited the
quality of the immune response elicited. Nevertheless, response, whereas postimmunization inoculation of
the immunomodulatory activity of some innate cyto- IFN-I enhanced antibody production. A similar influence
kines, including the type I interferons (IFN-I), remains of the timing of administration of IFN-I on the induction
largely unexplored. of DTH responses has also been reported (De Maeyer
IFN-I, the major species of which are IFN-a and -b, and De Maeyer-Guignard, 1980). Since expression of
are expressed at low levels under normal physiological IFN-I after exposure to antigen was obviously more anal-
conditions but are induced to high levels by a number ogous to events occurring during a natural infection, the
of stimuli, including viral or bacterial infection and expo- results together imply that virus-induced IFN-I could
sure to double-stranded RNA (Belardelli et al., 1984; play a role in enhancing the immune response. However,
Kirchner, 1984; Bogdan, 2000). IFN-I are produced not these studies were limited by the lack of availability of
reagents for showing definitively that the effects were
mediated by IFN-I and for measuring the isotypes of§ To whom correspondence should be addressed (e-mail: david.
tough@jenner.ac.uk). antibodies produced. In addition, the use of sheep red
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Figure 1. Poly IC Enhancement of the Primary Antibody and T Cell Response to CGG
B6 (A) or 129 and IFN-IR KO mice (B–D) were injected with poly IC, CGG, or CGG 1 poly IC as indicated. The sera and DrLNs were obtained
10 days later.
(A) Antibody response in B6 mice injected with CGG alone or CGG 1 poly IC.
(B) Antibody response in 129 (white bars) or IFN-IR KO (black bars) mice injected with CGG alone or CGG 1 poly IC. Antibody responses are
expressed as the mean 6 SD of endpoint titers.
(C) In vitro proliferation of T cells from 129 or IFN-IR KO mice primed by injection of poly IC, CGG, or CGG 1 poly IC. Cell suspensions from
the DrLNs of 129 or IFN-IR KO mice were cultured 6 CGG as indicated and pulsed with [3H]thymidine on the fourth day of culture.
(D) IFN-g secretion by CD41 T cells from 129 or IFN-IR KO mice primed by injection of poly IC, CGG, or CGG 1 poly IC. CD41 T cells purified
from the DrLNs of immunized 129 or IFN-IR KO mice were cultured together with T-depleted spleen cells from nonimmunized syngeneic
mice 6 CGG as indicated. Supernatants were harvested on day 3 of culture and assayed for the presence of IFN-g by ELISA. Data are derived
from three to five mice per group.
blood cells, which induce strong immune responses on The results show that IFN-I possess strong adjuvant
activity, markedly enhancing the antibody responsetheir own, may have restricted the ability to detect an
enhancement of the response by IFN-I. against a poorly immunogenic soluble protein. IFN-I
augmented the production of all subclasses of IgG dur-Other evidence that IFN-I may have immunostimula-
tory activity has come from a series of studies in trans- ing the primary antibody response and induced both
long-term antibody production and immunological mem-plantable tumor cell models (Belardelli and Gresser,
1996). Here it was found that rejection of IFN-resistant ory after a single injection of soluble protein. In addition,
evidence is presented that implicates DC as target cellstumors was often enhanced by either coinjection of IFN-I
or transfection of tumor cells with genes encoding IFN-a. for the adjuvanticity of IFN-I in vivo.
Furthermore, this increased rejection appeared to be
immune mediated and in some cases was associated Results
with the induction of tumor-specific antibodies (Gresser
et al., 1991). Induction of Endogenous IFN-I Enhances
the Primary Antibody ResponseFinally, there is evidence to suggest that IFN-I may
influence the isotypes of antibodies secreted during an As an initial approach to determine whether IFN-I modu-
late antibody responses, we injected mice with polyino-immune response (Finkelman et al., 1991). Hence, in
mice stimulated to make a large polyclonal Ig response sinic:polycytidylic acid (poly IC), a synthetic double-
stranded RNA, to induce production of IFN-I in vivoby injection of anti-IgD antibodies, treatment with IFN-a
enhanced IgG2a levels while reducing the titers of IgG1 (Field et al., 1967). Thus, we immunized C57BL/6 (B6)
mice by injecting chicken gamma globulin (CGG) in PBSand IgGE antibodies. Whether IFN-I would have similar
effects on an antigen-specific antibody response is un- sc and examined the effect of coinjecting poly IC. Ten
days after immunization, the sera were assayed byknown.
In the current study, we have examined directly how ELISA for the presence of CGG-specific antibodies of
various isotypes (Figure 1A). CGG alone was poorly im-induction or administration of IFN-I at the site of immuni-
zation affects the generation of an immune response. munogenic, and the response was largely restricted to
Potent Adjuvant Activity of Type I Interferons
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Figure 2. Enhancement of the Primary Antibody Response to CGG by Injection of IFN-I
(A and B) Antibody response in B6 mice immunized with CGG alone or immunized with CGG and treated with IFN-a/b.
(C) Frequency of cells secreting CGG-specific antibodies in DrLNs of B6 mice immunized with CGG alone or immunized with CGG and treated
with IFN-a/b. Data are expressed as the number of cells secreting CGG-specific antibodies of particular isotypes per 5 3 105 total LN cells.
(D) Antibody response in B6 mice immunized with CGG alone or immunized with CGG and treated with IFN-b. All mice received a single
injection of CGG. Those also receiving soluble IFN-a/b or IFN-b were injected with the respective IFN either only at the time of immunization
(13) or given additional injections of IFN 1 day later (23) or 1 and 2 days later (33). In (B) and (C), IFN-treated mice were given three injections
of IFN-a/b. At day 10, mice were bled and their sera assayed for the presence of CGG-specific antibodies by ELISA. Antibody responses are
expressed as the mean 6 SD of endpoint titers, except in (B), where the approximate quantities of CGG-specific antibodies were determined
by comparison with isotype standards (three mice per group).
antibodies of the IgG1 subclass; IgM, IgG2b, IgG2a, of the effect of poly IC was dependent on IFN-I, since
the titers of these antibodies remained much lower inand IgG3 antibodies were detected at very low levels.
Coinjection of poly IC stimulated a clear-cut increase in IFN-IR KO mice than in control mice. Furthermore, pro-
duction of IgG2a and IgG3 anti-CGG antibodies was notCGG-specific antibody titers, which applied to all sub-
classes of IgG (Figure 1A). This included 3-, 4.2-, 9-, and stimulated at all by poly IC in IFN-IR KO mice. Taken
together, these data show that induction of expression8.4-fold increases in the titers of IgG1, IgG2b, IgG2a,
and IgG3 antibodies, respectively. Poly IC similarly en- of IFN-I in the host stimulates a markedly increased
antibody response to a soluble protein antigen, whichhanced the antibody response to another soluble pro-
tein, ovalbumin (data not shown). includes antibodies of all IgG subclasses.
The effect of inducing IFN-I on T cell priming wasAlthough poly IC is known to be a potent inducer of
IFN-I, it also induces other cytokines (Snapper et al., also assessed. This was done initially by measuring the
capacity of LN T cells to proliferate upon restimulation1991; Roman et al., 1997). Therefore, it was important
to determine whether the adjuvant activity of poly IC with CGG in vitro. Draining LNs (DrLNs) were removed
10 days after immunization and the resulting cell sus-was in fact dependent on IFN-I. To do so, we compared
the ability of poly IC to enhance the antibody response pensions cultured in the presence or absence of CGG.
Coinjection of poly IC with CGG into control (129) micein mice lacking a functional receptor for IFN-I (IFN-IR
KO mice, which were on a 129 background) and in con- led to a much higher CGG-specific in vitro proliferative
response than immunization with CGG alone (Figure 1C);trol (129) mice. As in B6 mice, poly IC markedly enhanced
the antibody response to CGG in control 129 mice (Fig- pulsing with BrdU showed that most of the cells prolifer-
ating in vitro were CD41 (data not shown). The enhance-ure 1B). In contrast, poly IC had a greatly reduced ability
to do so in IFN-IR KO mice. Small increases in IgM, ment of T cell priming was partially independent of IFN-I,
since poly IC treatment of IFN-IR KO mice also resultedIgG1, and IgG2b titers were observed in IFN-IR KO mice,
indicating that poly IC can enhance the production of in some increase in the in vitro proliferative response
(Figure 1C). However, the proliferation of cells fromthese isotypes independently of IFN-I. However, most
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Figure 3. Comparison of Antibody Responses Enhanced by IFN-I and Oil-Based Adjuvants
B6 mice were immunized by sc injection of CGG, CGG 1 IFN-a/b, CGG emulsified in IFA, or CGG emulsified in TiterMax. All adjuvants were
given together with CGG on day 0 and then alone on day 1 and 2. Ten days after challenge with antigen, sera were assayed for the presence
of CGG-specific antibodies by ELISA. Results are expressed as the mean 6 SD of endpoint titers (three mice per group).
CGG 1 poly IC–injected IFN-IR KO mice was much lower IgG1, 13.3-, 16-, and 26.6-fold for IgG2b, 25.6-, 32-, and
153.6-fold for IgG2a, and 16.6-, 64-, and 117.3-fold forthan that of cells from CGG 1 poly IC–injected control
IgG3. Taken together with the experiment using partiallymice, indicating that IFN-I were in fact strongly enhanc-
purified IFN-a/b, these results clearly show that adminis-ing the T cell response in vivo. This was also evident
tration of IFN-I early during an immune response mark-when cytokine production by in vitro restimulated CD41
edly increases the primary antibody response to a solu-T cells was examined (Figure 1D). Thus, while CD41
ble protein antigen.DrLN cells from mice immunized with CGG alone se-
creted little if any IFN-g when stimulated by CGG in vitro,
Comparison between IFN-I and Other Adjuvantsmarkedly higher amounts of IFN-g were produced by
To evaluate further the efficiency of IFN-I as an adjuvant,CD41 cells from poly IC 1 CGG-injected mice. Impor-
we compared their capacity to enhance the primary anti-tantly, poly IC augmented the priming of IFN-g-secreting
body response with that of commercial adjuvants. InitialCD41 T cells to a much greater extent in control mice
comparisons were made with two oil-based adjuvants,than in IFN-IR KO mice. In contrast, low amounts of IL-4
incomplete Freund’s adjuvant (IFA) and Titermax (Figurewere secreted from CD41 cells in all groups that were not
3). Although IFA and Titermax stimulated higher levelssignificantly different from each other (data not shown).
of IgG1 antibodies, IFN-I were equivalent to these adju-Thus, induction of IFN-I in vivo enhances T cell priming,
vants in ability to induce IgM and IgG2b antibodies andpromoting the generation of IFN-g-secreting CD41 T
were far superior in increasing the production of IgG2acells.
and IgG3 antibodies.
As a stricter test of adjuvant activity, IFN-I were com-
Stimulation of Primary Antibody Responses pared to complete Freund’s adjuvant (CFA). CFA has
by Treatment with IFN-I long been considered the “gold standard” for adjuvant
The effect of exogenous IFN-I on antibody responses activity in mice and is known to enhance the production
was studied initially using a partially purified high titers of antibodies of all isotypes. Thus, we compared CGG-
preparation of murine IFN-I, which contained both IFN-a specific antibody titers, 10 days after immunization, in
and IFN-b. B6 mice were injected sc with CGG alone or mice injected with CGG alone, CGG 1 CFA, or CGG 1
CGG 1 IFN-a/b (IFN 13). In addition, separate groups IFN-a/b; antibody responses were measured in B6 mice
of mice injected with CGG 1 IFN-a/b received a second (Figure 4A) and in 129 mice (Figure 4B, white bars). As
sc injection of IFN-a/b alone 1 day later (IFN 23) or sc expected, antibody titers were higher in mice injected
injections of IFN-a/b both 1 and 2 days later (IFN 33). with CGG 1 IFN-a/b or CGG 1 CFA than in those immu-
As shown in Figures 2A and 2B, treatment of mice with nized with CGG alone. Remarkably, the adjuvant activity
IFN-a/b strongly enhanced the CGG-specific antibody of IFN-a/b compared favorably with that of CFA. In fact,
response; the effect was most marked in mice receiving although CFA induced higher titers of IgM antibodies
three injections of IFN-I and was apparent for all sub- (on the 129 background only), IFN-a/b stimulated the
classes of IgG. CGG-specific IgE was not detectable in production of similar titers of IgG1 and IgG2b antibodies.
any group of mice (data not shown). Treatment with IFN- Furthermore, IFN-a/b induced higher levels of IgG2a
a/b similarly enhanced the antibody response in LPS- and, at least on the 129 background, IgG3 antibodies
nonresponsive C3H/HeJ mice, discounting the possibil- than CFA. These results showed, therefore, that IFN-
ity of contamination with endotoxin (data not shown). a/b does indeed have powerful adjuvant activity. The
In addition to augmented serum antibody levels, higher effects are particularly significant when it is considered
numbers of antibody-secreting cells were detected in that the responses being compared were those to solu-
the DrLNs of IFN-a/b-treated mice (Figure 2C). ble protein 1 soluble IFN-a/b, which are likely cleared
A similar experiment was performed using affinity- rapidly, and to the oily emulsion of CFA, which can
purified IFN-b (Figure 2D). In this case, a single injection persist at the site of injection for a long period of time.
of IFN-b was sufficient to enhance the primary antibody
response, although, as for the partially purified IFN-a/b, Role of Endogenous IFN-I in the Adjuvant Activity
the highest antibody titers were achieved after three of CFA and in Stimulation of the Response
injections of IFN-b. After one, two, or three injections of to Protein Alone
IFN-b, antibody titers were increased, respectively, A notable difference between the adjuvant activities of
CFA and IFA or Titermax is that only the former was able5-, 6-, and 8-fold for IgM, 6.4-, 8.5-, and 12.8-fold for
Potent Adjuvant Activity of Type I Interferons
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Figure 4. CFA Enhancement of Antibody Responses Is Similar to that Induced by Soluble IFN-a/b and Is Dependent on Endogenous IFN-I
(A) Comparison of antibody response in B6 mice injected with CGG alone, CGG 1 IFN-a/b, or CGG 1 CFA.
(B) Comparison of antibody response in WT 129 (white bars) or IFN-IR KO (black bars) mice injected with CGG alone, CGG 1 IFN-a/b, or
CGG 1 CFA. Mice were immunized on day 0 by sc injection of CGG alone, CGG 1 IFN-a/b, or CGG emulsified in CFA. Mice received two
more injections of IFN-a/b on day 1 and 2 postimmunization. At day 10, mice were bled and their sera assayed for the presence of CGG-
specific antibodies by ELISA. Results are expressed as the mean 6 SD of endpoint titers (three mice per group).
to induce significant titers of IgG2a or IgG3 antibodies. alone. As shown in Table 1, mice treated with anti-IFN-
a/b showed a dramatic decrease in their ability to mountSince this is a property shared by IFN-I, it raised the
an antibody response to CGG. The titers of all sub-question of whether the ability of CFA to do so was
classes of IgG were reduced, while the production ofrelated to induction of endogenous IFN-I by this adju-
IgM was not inhibited. Taken together with the data fromvant. That IFN-I were induced by CFA seemed likely,
the IFN-IR KO mice (Figures 1B and 4B), these resultsgiven that a key constituent of CFA is heat-killed myco-
showed that background production of IFN-I can modifybacteria, and bacterial components such as CpG DNA
significantly the humoral response to a soluble protein.are known to stimulate production of IFN-I (Sun et al.,
1998b).
To test this hypothesis, we compared the antibody Induction of Long-Term Antibody Production
response to CGG in IFN-IR KO and control mice (Figure and Memory by IFN-I
4B). As expected, IFN-a/b was completely unable to Having shown that IFN-I enhanced the primary antibody
enhance the response to CGG in IFN-IR KO mice. Impor- response, it was of interest to determine whether this
tantly, the ability of CFA to promote the antibody re- response was long lasting. Initially, we tested for long-
sponse was also highly deficient in IFN-IR KO mice. term antibody production by assaying the sera of mice
Although CFA still induced high titers of IgG1 antibodies 6 months after a single injection of CGG or CGG 1 three
in IFN-IR KO mice, there was no longer any enhance- injections of IFN-a/b (Figure 5A). Mice primed with CGG
ment of IgM, IgG2b, IgG2a, or IgG3 antibodies compared alone had extremely low levels of CGG-specific antibody
to immunization with CGG alone. These results demon- after 6 months. In contrast, mice primed with CGG 1
strate an important role for IFN-I in the adjuvant activity
of CFA.
It was also noted that the antibody response to CGG Table 1. Treatment with Anti-IFN-a/b Reduces Antibody Response
alone, although low, was consistently higher in control to CGG Alone
mice than in IFN-IR KO mice (Figures 1B and 4B). This Isotype % Inhibition
suggested that the activity of low levels of “spontane-
IgM 225ous” IFN-I might actually be important in the generation
IgG1 76.25
of an immune response to a soluble protein antigen IgG2b 94.45
in the absence of adjuvant. To address this possibility IgG2a 77.08
further, we injected sheep anti-IFN-a/b Ig into normal IgG3 94.06
129 mice to neutralize endogenous IFN-I and tested the 129 mice were either left untreated or received a prior injection of
effect on the antibody response to CGG alone. Mice anti-IFN-a/b antibody 4 days before and on the day of immunization
were injected with anti-IFN-a/b antibodies twice: 4 days with CGG. CGG-specific antibody titer were determined by ELISA
10 days after immunization. Results are expressed as a percentageprior to priming and on the day of priming with CGG.
of inhibition of the antibody response to CGG by treatment withTen days after immunization, the antibody titers were
anti-IFN-a/b.
determined and compared to mice injected with CGG
Immunity
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Figure 5. IFN-I Stimulate Long-Term Antibody Production and Immunological Memory
(A) Endpoint antibody titers in B6 mice immunized 6 months earlier by injection of CGG alone or CGG 1 IFN-a/b. B6 mice were immunized
on day 0 by sc injection of either CGG alone or CGG 1 IFN-a/b. IFN-a/b treated mice received two more injections of IFN-a/b on day 1 and
2 postimmunization. Six months after immunization, mice were bled and their sera assayed for the presence of CGG-specific antibodies by
ELISA.
(B) Antibody response 6 days after CGG challenge in naı¨ve mice (No) and in mice immunized 6 months before with CGG alone or CGG 1
IFN-a/b. Immunized mice had been primed as in (A). CGG challenge was with CGG alone. Results represent antibody endpoint titers before
(white bars) and 6 days after challenge (black bars) expressed as the mean 6 SD of endpoint titers (three mice per group).
IFN-a/b still had significant titers of CGG-specific anti- mice. These results clearly showed that IFN-I promoted
bodies in their sera. With the exception of IgG3, for the generation of long-lived memory after a single injec-
which titers were very low and not significantly different tion of a soluble protein antigen.
from those in mice primed with CGG alone, antibodies
of all tested isotypes were present. Thus, injection of
IFN-I during priming allowed for long-term antibody pro- Enhancement of the Antibody Response
duction. and Isotype Switching Occurs through
It remains controversial whether long-term antibody Stimulation of Dendritic Cells by IFN-I
production is maintained by long-lived plasma cells or While IFN-I were clearly capable of markedly aug-
by replenishment of antibody-producing cells from menting both the magnitude of the antibody response
memory B cells. Nevertheless, there is strong evidence and switching to various IgG subclasses, their mecha-
that the former do exist (Manz et al., 1997; Slifka et al., nism of action in vivo was unknown. However, since
1998), raising the theoretical possibility that the produc- recent studies have shown that IFN-I can promote the
tion of antibodies detected 6 months after injection with maturation of human (Luft et al., 1998; Paquette et al.,
CGG 1 IFN-a/b could have persisted in the absence of 1998; Radvanyi et al., 1999; Santini et al., 2000) and
memory B cells. Therefore, it was of interest to investi- mouse (Gallucci et al., 1999) DC in vitro, one possibility
gate whether memory was also induced by immuniza- was that IFN-I may also be acting on these cells in
tion in the presence of IFN-I. To do so, we examined
vivo. To test this hypothesis, we designed an adoptive
the ability of mice primed 6 months earlier to mount a
transfer model in which DC were the only cells capable
secondary response to CGG. Thus, mice that had been
of responding to IFN-a/b. In these experiments, highlyinjected 6 months previously with CGG alone or CGG 1
purified splenic DC from wild-type 129 mice or IFN-IRthree injections of IFN-a/b were reinjected with CGG
KO mice were incubated briefly with CGG and injectedalone. To minimize the contribution from a primary re-
sc into IFN-IR KO recipients with or without IFN-a/b.sponse to CGG, the secondary response was studied
Mice receiving CGG 1 DC 1 IFN-a/b were given twoon day 6 after challenge and naive, nonprimed mice
further injections of IFN-a/b as before. CGG-specificwere used as controls. CGG-specific antibody titers
antibody titers were then measured on day 10 after im-were compared in the same mice before and after rein-
munization (Figure 6). As expected, IFN-a/b treatmentjection of CGG (Figure 5B). In mice primed 6 months
of mice receiving CGG 1 IFN-IR KO DC did not enhanceearlier with CGG alone, the response to CGG challenge
the antibody response, since no cells in these mice werewas indistinguishable from that in naive mice, indicating
able to respond to IFN-I. Conversely, injection of IFN-that there was no memory to CGG 6 months after priming
a/b into mice receiving CGG 1 wild-type DC inducedwith CGG alone. In marked contrast, however, mice
an increase in antibody titers for all four IgG subclassesprimed 6 months previously with CGG 1 IFN-a/b did
compared to injection of CGG 1 wild-type DC alone.mount a rapid secondary response to CGG. The second-
Therefore, not only does stimulation of DC by IFN-I en-ary response appeared, however, to be restricted to
hance the antibody response to coinjected protein, it isIgG2b and IgG2a antibody isotypes, despite the fact
that high titers of IgG1 antibodies persisted in these sufficient to induce isotype switching.
Potent Adjuvant Activity of Type I Interferons
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Figure 6. DC Responsive to IFN-I Are Sufficient for Enhancement of Antibody Production and Isotype Switching by IFN-I
Purified splenic DC were prepared from 129 mice (wt) or from IFN-IR KO mice, incubated briefly with CGG, and injected with (black bars) or
without (white bars) IFN-a/b sc into IFN-IR KO mice. Mice injected with DC 1 CGG 1 IFN-a/b received two more injections of IFN-a/b on
days 1 and 2 postimmunization. After 10 days, sera were assayed for the presence of CGG-specific antibodies by ELISA. Results are expressed
as the mean 6 SD of endpoint titers (three mice per group).
Discussion IgG1 titers were not increased after challenge, despite
the fact that these mice had high levels of IgG1 antibod-
ies before challenge. These results are reminiscent of aUnlike purified protein antigens, infectious agents typi-
cally induce strong immune responses without the need previous report in which initial priming with tetanus tox-
oid in the presence of mouse hepatitis virus led to afor exogenous adjuvants. The implication is that nonan-
tigen-specific signals induced by infection provide natu- secondary anti-tetanus response that included IgG2a
but not IgG1 antibodies (Coutelier et al., 1991). The impli-ral adjuvant activity, signaling the immune system to
respond. We have shown here that such a signal can cation is that the virus-induced bias in the memory re-
sponse may also have been mediated by IFN-I. Thebe provided by IFN-I. Thus, treatment of mice with IFN-
a/b or induction of endogenous IFN-I by substances reason for the lack of secondary IgG1 response is un-
known but could indicate that memory B cells express-such as poly IC or CFA potently augmented the antibody
response to a soluble protein. The adjuvant activity of ing IgG1 are either not present or are driven to further
isotype switching by interaction with memory T cells.soluble IFN-I was remarkably powerful, as exemplified
by its ability to augment the primary antibody response The latter is worth considering, since there is consider-
able evidence that IgG1-producing B cells can switchto a similar extent as emulsification of the antigen in
CFA. Furthermore, IFN-I were shown to enhance the to IgE production (Yoshida et al., 1990; Siebenkotten et
al., 1992; Mandler et al., 1993).production of antigen-specific antibodies of all sub-
classes of IgG and induced IgG2a and IgG3 antibodies Soluble IFN-I and CFA induced CGG-specific anti-
body responses that were similar in both magnitude andfar more effectively than widely used adjuvants such as
IFA or Titermax. isotype distribution, which led us to investigate whether
induction of IFN-I by CFA played a role in its adjuvantAs well as enhancing the primary response, IFN-I were
also able to induce long-term antibody production after activity. Experiments in IFN-IR KO mice demonstrated
that the capacity to respond to IFN-I was in fact essentiala single injection of soluble protein, which was remark-
able considering the probable short half-life of both the for the adjuvant activity of CFA, particularly with regard
to its ability to induce Ig class switching to IgG2b, IgG2a,antigen and the IFN-I in vivo. Thus, antibodies were still
detectable 6 months after immunization in mice injected and IgG3 subclasses of IgG. These findings raise the
question of whether the induction of IFN-I might alsowith CGG 1 IFN-a/b but not in mice injected with CGG
alone. The issue of whether this reflected antibody pro- be an important aspect of the activity of other adjuvants.
Bacterial or CpG-containing DNA may be an interestingduction by long-lived plasma cells or by shorter lived
plasma cells that were renewed from memory B cells example in this regard, since it is able to act as an
adjuvant in the promotion of IgG2a, IgG2b, and IgG3was not addressed in this paper, but it is of interest that
long-lived plasma cells have been detected after virus responses (Roman et al., 1997; Sun et al., 1998a) and
induces partial activation of T cells through a mecha-infection (Slifka et al., 1998). This raises the interesting
possibility that IFN-I are involved in the generation of nism that is dependent on IFN-I (Sun et al., 1998b).
The ability of IFN-I to induce IgG2a antibodies is inthese cells.
In addition, mice immunized with CGG and treated accord with work published by Finkelman et al., where
it was shown that administration of IFN-a enhancedwith IFN-a/b exhibited a memory response upon chal-
lenge with CGG 6 months later, producing CGG-specific IgG2a isotype switching in anti-IgD injected mice (Fin-
kelman et al., 1991). Notably, IFN-a did not promoteIgG2a and IgG2b antibodies within 6 days of injection
of antigen alone; memory was not observed in mice IgG2a production when added in vitro to LPS 1 IL-4
activated B cells, implying that class switching was me-immunized with CGG alone. Interestingly, CGG-specific
Immunity
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Briefly, confluent cells were primed by the addition of 10 U/ml ofdiated indirectly in vivo rather than through direct action
IFN in MEM enriched with 10% FCS and 1 mM sodium butyrate.of IFN-a on B cells. In the present study, we have identi-
After 16 hr of culture at 378C, C243-3 cells were infected by Newcas-fied DC as one target cell through which IFN-I can induce
tle disease virus (multiplicity of infection of 1) in MEM 1 0.5% FCS 1
isotype switching, with the demonstration that IFN-a/b 5 mM theofylline. Eighteen hours postinfection, culture supernatant
enhanced the production of not only IgG2a, but also was collected and centrifuged at 1500 rpm for 10 min. The superna-
IgG1, IgG2b, and IgG3 antibodies when DC were the tant was adjusted to pH 2.0 and kept at 08C for 6 days, before IFN
titration. IFN was assayed by inhibition of the cytopathic effect ofonly cell type able to respond directly to IFN-I in vivo.
vesicular stomatitis virus on L cells in monolayer culture in FlaconThus, although it cannot be ruled out that IFN-I exert
microplates. These IFN preparations had the specific activity of 2 3effects on additional cell types that contribute to their
106 U/mg of protein after removal by centrifugation of contaminating
adjuvant activity in normal mice, the adoptive transfer protein precipitated during the treatment at pH 2.0 and dialysis
experiments clearly showed that stimulation of DC with against PBS. Units in the text are expressed as international mouse
IFN-I is sufficient to enhance antibody production and reference units. IFN was concentrated and partially purified by am-
monium sulfate precipitations and dialysis against PBS. All IFN prep-isotype switching; how this is accomplished is unknown.
arations were further subjected to dialysis for 24 hr at 48C againstIt is possible that DC mediate the adjuvant activity of
0.01 M percloric acid and then against PBS before testing them forIFN-I strictly through enhancing and polarizing T cell
any possible residual toxicity on a line of L1210 cells resistant toresponses. As shown here, induction of IFN-I augments
IFN. These partially purified IFN preparations had a titers of at least
the priming of IFN-g-producing CD41 T cells. While it 2 3 107 U/mg of protein and were endotoxin free, as assessed by
seems likely that the elevated T cell response will con- the Limulus amebocyte assay. They proved to be constituted of
tribute to the increased magnitude of the antibody re- approximately 75% IFN-b and 25% IFN-a, as evaluated by neutral-
ization assays using mAbs to IFNs, as described in detail elsewheresponse, it is uncertain whether IFN-g production per se
(Belardelli et al., 1987). High titers purified IFN-b (2 3 109 U/mg ofis important for the effects of IFN-I on the antibody
protein) was prepared by affinity chromatography on a Sepharoseresponse. In this regard, it has been shown that IFN-a-
column coupled with rat monoclonal antibodies to IFN-b (Kawade
mediated enhancement of IgG2a isotype switching in and Watanabe, 1987).
anti-IgD-injected mice could not be blocked by anti-
IFN-g treatment (Finkelman et al., 1991). Furthermore, Protocols of Immunizations
our preliminary results have shown that IFN-I can aug- All immunizations were done by sc injection of 100 mg of CGG
ment antibody responses and induce isotype switching (Stratech Scientific Ltd., Luton, UK). CGG was administrated in solu-
ble form (in PBS) either when given alone or when mixed with 100in IFN-gR KO mice (A. L. B. et al., unpublished observa-
mg of poly IC (Sigma Chemical Co. Ltd., Dorset, UK), 105 U of IFN-tions), implying that IFN-g independence may also apply
a/b, or 105 U of purified IFN-b, as indicated. When injected withto the enhancement of antigen-specific humoral re-
Titermax (CytRx Corporation, Norcross, GA), IFA (Sigma), or CFAsponses by IFN-I. Therefore, if DC mediate the adjuvant
(Sigma), an equal volume of CGG in PBS was emulsified with the
activity of IFN-I solely through their effects on T cells, adjuvant before injection. In some experiments, IFN-I, Titermax, or
mechanisms of T cell–induced isotype switching that IFA were administered several times. In all cases, mice were injected
are unrelated to IFN-g secretion need to be considered. sc at the site of the primary injection. Where indicated, the neutraliz-
ing sheep anti-IFN-a/b Ig was administrated ip in PBS 4 days beforeAn alternative possibility is that isotype switching was
and at the time of injection with CGG. This antibody has been showndriven by non-T cells. The ability of CD40L2/2 mice to
to neutralize the activity of all IFN-I naturally produced after virusproduce IgG2a antibodies after virus infection suggests
infection of mouse cells but has no inhibitory activity against IFN-g
that typical T cell help may not be required for the isotype (Gresser et al., 1988). When testing for a memory response, mice
switch (Borrow et al., 1996). In this respect, IFN-stimu- were bled immediately prior to challenge with CGG to establish
lated DC might mediate their effects through direct inter- prechallenge antibody levels. The same mice were bled 6 days after
CGG challenge.action with B cells, since there is evidence to suggest
that isotype switching can be regulated by DC–B cell
Assay of Serum Antibody by ELISAcontact (Wykes et al., 1998). Regardless of the mecha-
CGG (5 mg/ml in carbonate buffer [pH 9.6]) was coated overnightnism, these results clearly show the importance of DC
at RT in 96-well flexible plates (Falcon, Becton Dickinson, Oxford,in linking the action of IFN-I to the adaptive immune
UK). The plates were blocked with PBS containing 4% powderedresponse. While earlier studies showed an effect of IFN-I
milk for 1 hr at 378C and then washed 33 in PBS-Tween (0.05%).
on the maturation of DC from precursors in vitro, here Twelve-fold serial dilutions of sera in PBS-1% milk were added to
IFN-I was shown to modulate the ability of mature DC the wells for 1 hr at RT. After three washes, biotinylated rat anti-
to alter the magnitude and the quality of an immune mouse antibodies (anti-mouse IgM [R6-60.2], IgG1 [A85-1], IgG2a
[R19-15], IgG2b [12-3], IgG3 [R40-82], or IgE [R35-72] [Becton Dick-response in vivo.
inson]) were added to the wells for 1 hr at RT. After three washes,
streptavidin-HRP (Becton Dickinson) was added for 1 hr at RT. OPDExperimental Procedures
tablets (Sigma) were used as peroxidase substrate. The reaction
was stopped by addition of 50 ml 3 M HCl before the highest dilutionMice
of the highest titers serum rose above background. Optical densitiesC57Bl/6 (B6) mice were purchased from Charles River-UK (Margate,
were read at 492 nm on a SPECTRAmax (Molecular Devices, Sun-Kent, UK) or from the SPF unit at the Institute for Animal Health
nyvale, CA). Results are expressed as reciprocal endpoint titers,(Compton, UK). C3H/HeJ mice were purchased from Harlan UK Ltd.
which were determined using an automated routine designed on(Blackthorn, UK). 129 SvEv (129) mice were purchased from the SPF
Excel. Briefly, a threshold of positivity for OD values was calculatedunit at the Institute for Animal Health. 129 background mice deficient
for each antibody isotype as the average 1 3 SD of all dilutionsfor type I IFN receptor function (IFN-IR KO) were originally purchased
from three control mouse sera (sera from either unmanipulated micefrom B&K Universal (North Humberside, UK) and were maintained
or mice treated with IFN-a/b or poly IC alone). The background leveland bred in the SPF unit at the Institute for Animal Health.
was very low at all dilutions (typically about 0.08) and did not vary
significantly between experiments. For a given serum sample, theInterferons
endpoint titers was determined as the first dilution below the thresh-High titers IFN-a/b (2 3 107 U/mg of protein) was prepared in the
C243-3 cell line following a method adapted from Tovey et al. (1974). old of positivity. Since endpoint titers are arbitrary units, the results
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must be considered inside the same assays and cannot be directly After five washes in PBS, plates were blocked for 2 hr with 4% milk
compared between experiments. For this reason, all samples within in PBS at 378C and washed five times in PBS. Cell suspensions
in each experiment were assayed at the same time. were prepared from DrLNs as described above, washed, centrifuged
To determine the approximate concentrations of CGG-specific at 1500 rpm for 10 min, and resuspended in complete medium
antibodies present in mouse sera, the ELISA was performed in a supplemented with 15% FCS. All samples were plated in triplicate
semiquantitative way by comparison to mouse Ig standards. CGG- at several different cell concentrations (from 2 3 104–5 3 105 cells/
specific antibodies were detected as described above, except that well). Following overnight culture at 378C in 5% CO2, plates were
antibodies were revealed using isotype-specific polyclonal goat then extensively washed with PBS-Tween (0.05%). CGG-specific
anti-mouse antibodies conjugated to alkaline phosphatase (AP) (all antibodies were revealed by incubating the wells with isotype-spe-
from Southern Biotechnology Associates Inc., Birmingham, AL). To cific polyclonal goat anti-mouse antibodies conjugated to AP
establish standards, plates were coated with unlabeled isotype- (Southern Biotechnology) for 2 hr at RT. After washes, BCIP (Sigma)
specific polyclonal goat anti-mouse antibodies (5 mg/ml) (Southern diluted in 0.1 M Tris/HCl (pH 9.5); 10% diethanolamine; 0.1 M NaCl,
Biotechnology). The plates were blocked as above and then purified 5 mM MgCl2 at 1 mg/ml was used as the substrate for AP. The
mouse antibodies were added at known concentration (mouse Ig reaction was stopped by washing the plates with tap water. Spots
Standard Panel from Southern Biotechnology). After washes, the were counted under a microscope.
standards were revealed using isotype-specific goat anti-mouse
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